12-11091727-A-C
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_176884.2(TAS2R43):āc.503T>Gā(p.Leu168Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000785 in 1,298,594 control chromosomes in the GnomAD database, including 32 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_176884.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000133 AC: 16AN: 120700Hom.: 5 Cov.: 20
GnomAD3 exomes AF: 0.0000400 AC: 8AN: 200222Hom.: 1 AF XY: 0.0000274 AC XY: 3AN XY: 109326
GnomAD4 exome AF: 0.0000730 AC: 86AN: 1177786Hom.: 27 Cov.: 47 AF XY: 0.0000692 AC XY: 41AN XY: 592440
GnomAD4 genome AF: 0.000132 AC: 16AN: 120808Hom.: 5 Cov.: 20 AF XY: 0.000170 AC XY: 10AN XY: 58914
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 16, 2024 | The c.503T>G (p.L168W) alteration is located in exon 1 (coding exon 1) of the TAS2R43 gene. This alteration results from a T to G substitution at nucleotide position 503, causing the leucine (L) at amino acid position 168 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at